Showing results (281-290 of 322) with videos related to
Sort By:
Pageof 33
Journal of the National Cancer Institute|December 10, 2024
Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological studyTroy J Kleber, Alexander D Sherry, Andrew J Arifin, et al.British Journal of Cancer|August 11, 2025
Bayesian interim analysis and efficiency of phase III randomized trialsAlexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.Oncotarget|August 22, 2013
Coordinated targeting of the EGFR signaling axis by microRNA-27a*Xiaoli Wu, Mihir K Bhayani, Cristina T Dodge, et al.JAMA Oncology|June 1, 2025
Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological AnalysisAlexander D Sherry, Avital M Miller, Jnana Preeti Parlapalli, et al.The Lancet. Child & Adolescent Health|May 8, 2018
Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort studyJennifer G Jetton, Louis J Boohaker, Sidharth K Sethi, et al.BMJ Oncology|January 31, 2025
Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trialsAlexander D Sherry, Pavlos Msaouel, Timothy A Lin, et al.Head & Neck|May 22, 2015
Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapyVinita Takiar, Dominic Ma, Adam S Garden, et al.Head & Neck|March 19, 2015
Orbital carcinomas treated with adjuvant intensity-modulated radiation therapyRanda Tao, Dominic Ma, Vinita Takiar, et al.Head & Neck|November 18, 2018
Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavityAshley C Mays, Ehab Y Hanna, Renata Ferrarotto, et al.International Journal of Cancer|August 14, 2024
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trialsAlexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.Pageof 33